Correction: Fragment-based covalent ligand discovery
Abstract
Correction for ‘Fragment-based covalent ligand discovery’ by Wenchao Lu et al., RSC Chem. Biol., 2021, DOI: 10.1039/d0cb00222d.
* Corresponding authors
a
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
E-mail:
nathanael_gray@dfci.harvard.edu
b Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA
c Center for Protein Degradation, Dana-Farber Cancer Institute, Boston, MA 02215, USA
d Vividion Therapeutics, La Jolla, CA 92121, USA
e Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA
Correction for ‘Fragment-based covalent ligand discovery’ by Wenchao Lu et al., RSC Chem. Biol., 2021, DOI: 10.1039/d0cb00222d.
W. Lu, M. Kostic, T. Zhang, J. Che, M. P. Patricelli, L. H. Jones, E. T. Chouchani and N. S. Gray, RSC Chem. Biol., 2021, 2, 670 DOI: 10.1039/D1CB90008K
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content